Bulgaria vs Egypt: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bulgaria
0.0%
in 2024
Egypt
0.0%
in 2024
Bulgaria rank
143rd
Egypt rank
143rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bulgaria
- Egypt
How they compare
Bulgaria currently reports 0.0% against 0.0% in Egypt, a difference of 0.0%.
Across all 10 years both countries report, Egypt has been ahead every year.
Bulgaria ranks 143rd and Egypt ranks 143rd of 215 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Egypt |
| 2020s | 0.0% | 0.0% | 0.0% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bulgaria or Egypt?
- Bulgaria, at 0.0% against 0.0% in Egypt as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bulgaria and Egypt?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Egypt?
- 10 years are reported by both, from 2015 to 2024.
- How do Bulgaria and Egypt rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bulgaria ranks 143rd and Egypt ranks 143rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.